<img alt="" src="https://secure.agile-company-247.com/261975.png" style="display:none;">

2022 Investival masterclasses

45-minute lecture-style masterclass workshops hosted by an expert partner.
They're focussed on critical strategic and transactional topics in investment, partnering and deal-making for life science and healthcare companies.

11:30 – 12:15    Early Growth Stage Funding

Presented by: Pinsent masons logo

This masterclass is designed to give you key success factors around the process of navigating the route to securing your first significant equity investment finance raise:

  • The different sorts of investors you will encounter
  • How best to engage with potential investors
  • An insight into the investors’ perspective
  • What terms to VCs and angel investors want in the investment documentation?
  • What should founders and management be looking out for in the investment documentation?
  • Q&A
Charles Waddell, Partner, Pinsent Masons
Rebecca Todd, Investment Director, Longwall Venture Partners
Charles Waddell, Partner, Pinsent MasonsRebecca Todd, Investment Director, Longwall Venture Partners

12:30 – 13:15   Licensing & Partnering

Presented by:Baker McKenzie Logo

Moving up the value chain: Out-licensing and collaboration agreement tactics

  • Different biotech models
  • Scope of licenses and IP ownership (retaining ownership, territory and indication splits)
  • Research and development (timing of transition, cost and resource considerations, coordination, profit/cost splits)
  • Manufacturing (timing of transition)
  • Commercialization (territory and indication splits, coordination, profit/cost splits, co-promotion, co-commercialization)
  • Economics (reach-through royalties, profit/cost split vs royalties, opt-in/out, budgets and other guardrails, decision-making)
Oren Livne, Partner, Global Life Sciences Transactions, Baker McKenzie
Hiroshi Sheraton, Partner, Baker McKenzie
Julie Yeni, Partner, Life Sciences, Baker McKenzie
Julia Schieber, Partner, Baker McKenzie

Oren Livne, Partner, Baker McKenzieHiroshi Sheraton, Partner, Baker McKenzieJulie Yeni, Partner, Life Sciences, Baker McKenzieJulie Schieber, Associate, Baker McKenzie

13:30 – 14:15    M&A Strategies

Presented by:Latham & Watkins Logo

This session will discuss the key considerations and potential issues when considering preparing a company for M&A:

  • Timelines
  • Ways to exit
  • Initial considerations
  • Key steps in the process
  • Vendor due diligence
  • W&I insurance
Robbie McLaren, Partner, Latham & Watkins
Samantha Peacock, Associate, Latham & Watkins
Emily Cridland, Partner, Latham & Watkins
Robbie McLaren, Partner, Latham & WatkinsSamantha Peacock, Associate, Latham & WatkinsEmily Cridland, Partner, Latham & Watkins

14:30 – 15:15    IPO Preparedness

Presented by:Covington Logo

  • Introduction
  • Making sure the ship is seaworthy for going public
  • Preparing for the going public transaction
  • Preparing for banker involvement
  • Home country preparation

Simon Amies, Partner, Covington & Burling
Matthew Gehl, Partner, Covington & Burling
Brandon Thompson, Partner, Covington & Burling

Simon Amies, Partner, Covington & BurlingMatthew Gehl, Partner, Covington & BurlingBrandon Thompson, Special Counsel, Covington

15:30 – 16:15    Late-Growth Stage Funding

  • Introduction
  • The current late growth financing environment
  • Understanding and being prepared for late-growth stage fundraisings
  • Flexible financing and M&A - the current state of the growth market
  • Q&A

Presented by:White & Case Logo

Philip Broke, Partner, White & Case
Martin Forbes, Partner, White & Case
Emmie Jones, Partner, White & Case
Daniel Turgel, Partner, White & Case

Philip Broke, Partner, White & CaseMartin Forbes, Partner, White & CaseEmmie Jones, Partner, White & CaseDaniel Turgel, Partner, White & Case